{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:29:38Z","timestamp":1793690978032,"version":"4.5.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,6]]},"DOI":"10.7759\/cureus.44784","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T13:12:43Z","timestamp":1694005963000},"source":"Crossref","is-referenced-by-count":0,"title":["Pretreatment Embolization of Tumoral Arteriovenous Fistula Associated With Recanalized Umbilical Vein Shunt in a Case of Hepatocellular Carcinoma With Hepatic Vein and Inferior Vena Cava Invasion"],"prefix":"10.7759","author":[{"given":"Joey","family":"Almaguer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsalan","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S61146","article-title":"Hepatocellular carcinoma: a review","volume":"3","author":"Balogh J","year":"2016","unstructured":"Balogh J, Victor D 3rd, Asham EH, et al.. Hepatocellular carcinoma: a review. J Hepatocell Carcinoma. 2016, 3:41-53. 10.2147\/JHC.S61146","journal-title":"J Hepatocell Carcinoma"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet JM","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, et al.. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021, 7:6. 10.1038\/s41572-020-00240-3","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3180381584","article-title":"Mechanisms of synergy between alcohol and hepatitis C virus","volume":"41","author":"Singal AK","year":"2007","unstructured":"Singal AK, Anand BS. Mechanisms of synergy between alcohol and hepatitis C virus. J Clin Gastroenterol. 2007, 41:761-72. 10.1097\/MCG.0b013e3180381584","journal-title":"J Clin Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228857","article-title":"The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis","volume":"15","author":"Zhang J","year":"2020","unstructured":"Zhang J, Chen G, Zhang P, et al.. The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. PLoS One. 2020, 15:e0228857. 10.1371\/journal.pone.0228857","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-1-200307010-00012","article-title":"Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis","volume":"139","author":"Gupta S","year":"2003","unstructured":"Gupta S, Bent S, Kohlwes J. Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann Intern Med. 2003, 139:46-50. 10.7326\/0003-4819-139-1-200307010-00012","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig M","year":"2022","unstructured":"Reig M, Forner A, Rimola J, et al.. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022, 76:681-93. 10.1016\/j.jhep.2021.11.018","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12286","article-title":"New concepts in the treatment of hepatocellular carcinoma","volume":"10","author":"Sidali S","year":"2022","unstructured":"Sidali S, Tr\u00e9po E, Sutter O, Nault JC. New concepts in the treatment of hepatocellular carcinoma. United European Gastroenterol J. 2022, 10:765-74. 10.1002\/ueg2.12286","journal-title":"United European Gastroenterol J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0324-7","article-title":"Transarterial radioembolization with Yttrium-90 for the treatment of hepatocellular carcinoma","volume":"33","author":"Kallini JR","year":"2016","unstructured":"Kallini JR, Gabr A, Salem R, Lewandowski RJ. Transarterial radioembolization with Yttrium-90 for the treatment of hepatocellular carcinoma. Adv Ther. 2016, 33:699-714. 10.1007\/s12325-016-0324-7","journal-title":"Adv Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2021210014","article-title":"Evolution of radioembolization in treatment of hepatocellular carcinoma: a pictorial review","volume":"41","author":"Miller FH","year":"2021","unstructured":"Miller FH, Lopes Vendrami C, Gabr A, et al.. Evolution of radioembolization in treatment of hepatocellular carcinoma: a pictorial review. Radiographics. 2021, 41:1802-18. 10.1148\/rg.2021210014","journal-title":"Radiographics"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S385478","article-title":"Yttrium-90 radioembolization as the major treatment of hepatocellular carcinoma","volume":"10","author":"Yu CY","year":"2023","unstructured":"Yu CY, Huang PH, Tsang LL, et al.. Yttrium-90 radioembolization as the major treatment of hepatocellular carcinoma. J Hepatocell Carcinoma. 2023, 10:17-26. 10.2147\/JHC.S385478","journal-title":"J Hepatocell Carcinoma"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2016152100","article-title":"Hepatopulmonary shunting: a prognostic indicator of survival in patients with metastatic colorectal adenocarcinoma treated with (90)Y radioembolization","volume":"282","author":"Narsinh KH","year":"2017","unstructured":"Narsinh KH, Van Buskirk M, Kennedy AS, et al.. Hepatopulmonary shunting: a prognostic indicator of survival in patients with metastatic colorectal adenocarcinoma treated with (90)Y radioembolization. Radiology. 2017, 282:281-8. 10.1148\/radiol.2016152100","journal-title":"Radiology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/cld.908","article-title":"Position 2: transarterial radioembolization should be the primary locoregional therapy for unresectable hepatocellular carcinoma","volume":"15","author":"Rahman SI","year":"2020","unstructured":"Rahman SI, Nunez-Herrero L, Berkes JL. Position 2: transarterial radioembolization should be the primary locoregional therapy for unresectable hepatocellular carcinoma. Clin Liver Dis (Hoboken). 2020, 15:74-6. 10.1002\/cld.908","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5125","article-title":"TACE versus TARE for patients with hepatocellular carcinoma: overall and individual patient level meta analysis","volume":"12","author":"Brown AM","year":"2023","unstructured":"Brown AM, Kassab I, Massani M, et al.. TACE versus TARE for patients with hepatocellular carcinoma: overall and individual patient level meta analysis. Cancer Med. 2023, 12:2590-9. 10.1002\/cam4.5125","journal-title":"Cancer Med"},{"key":"ref14","article-title":"Comparison of post-embolization syndrome in the treatment of patients with unresectable hepatocellular carcinoma: trans-catheter arterial chemo-embolization versus yttrium-90 glass microspheres","volume":"3","author":"JE Goin","year":"2004","unstructured":"JE Goin, CA Roberts, JE Dancey, et al.. Comparison of post-embolization syndrome in the treatment of patients with unresectable hepatocellular carcinoma: trans-catheter arterial chemo-embolization versus yttrium-90 glass microspheres. World J Nucl Med. 2004, 3:49-56.","journal-title":"World J Nucl Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21980","article-title":"Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis","volume":"47","author":"Kulik LM","year":"2008","unstructured":"Kulik LM, Carr BI, Mulcahy MF, et al.. Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology. 2008, 47:71-81. 10.1002\/hep.21980","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.04.028","article-title":"Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization","volume":"11","author":"Salem R","year":"2013","unstructured":"Salem R, Gilbertsen M, Butt Z, et al.. Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization. Clin Gastroenterol Hepatol. 2013, 11:1358-65.e1. 10.1016\/j.cgh.2013.04.028","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-018-1802-y","article-title":"Comparison of health-related quality of life after transarterial chemoembolization and transarterial radioembolization in patients with unresectable hepatocellular carcinoma","volume":"44","author":"Kirchner T","year":"2019","unstructured":"Kirchner T, Marquardt S, Werncke T, et al.. Comparison of health-related quality of life after transarterial chemoembolization and transarterial radioembolization in patients with unresectable hepatocellular carcinoma. Abdom Radiol (NY). 2019, 44:1554-61. 10.1007\/s00261-018-1802-y","journal-title":"Abdom Radiol (NY)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-022-03072-8","article-title":"TARE in hepatocellular carcinoma: from the right to the left of BCLC","volume":"45","author":"Guiu B","year":"2022","unstructured":"Guiu B, Garin E, Allimant C, Edeline J, Salem R. TARE in hepatocellular carcinoma: from the right to the left of BCLC. Cardiovasc Intervent Radiol. 2022, 45:1599-607. 10.1007\/s00270-022-03072-8","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/j.2205-0140.2012.tb00013.x","article-title":"The development, structure and blood flow within the umbilical cord with particular reference to the venous system","volume":"15","author":"Spurway J","year":"2012","unstructured":"Spurway J, Logan P, Pak S. The development, structure and blood flow within the umbilical cord with particular reference to the venous system. Australas J Ultrasound Med. 2012, 15:97-102. 10.1002\/j.2205-0140.2012.tb00013.x","journal-title":"Australas J Ultrasound Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2020.07.012","article-title":"Umbilical vein recanalization","volume":"361","author":"Michaud M","year":"2021","unstructured":"Michaud M, Ranaivojaona S, Livideanu C, Mery C, Gaches F. Umbilical vein recanalization. Am J Med Sci. 2021, 361:e41. 10.1016\/j.amjms.2020.07.012","journal-title":"Am J Med Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.139.6.1107","article-title":"Recanalized umbilical vein in portal hypertension","volume":"139","author":"Aagaard J","year":"1982","unstructured":"Aagaard J, Jensen LI, S\u00f8rensen TI, Christensen U, Burcharth F. Recanalized umbilical vein in portal hypertension. AJR Am J Roentgenol. 1982, 139:1107-10. 10.2214\/ajr.139.6.1107","journal-title":"AJR Am J Roentgenol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/s0009-9260(97)80303-0","article-title":"Arteriovenous shunting in hepatocellular carcinoma: its prevalence and clinical significance","volume":"52","author":"Ngan H","year":"1997","unstructured":"Ngan H, Peh WC. Arteriovenous shunting in hepatocellular carcinoma: its prevalence and clinical significance. Clin Radiol. 1997, 52:36-40. 10.1016\/s0009-9260(97)80303-0","journal-title":"Clin Radiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrnm.2014.01.001","article-title":"The relationship between the percentage of lung shunting on Tc-99m macroaggregated albumin (Tc-99m MAA) scan and the grade of hepatocellular carcinoma vascularity","volume":"45","author":"Refaat R","year":"2014","unstructured":"Refaat R, Hassan MS. The relationship between the percentage of lung shunting on Tc-99m macroaggregated albumin (Tc-99m MAA) scan and the grade of hepatocellular carcinoma vascularity. Egypt J Radiol Nucl Med. 2014, 45:333-42. 10.1016\/j.ejrnm.2014.01.001","journal-title":"Egypt J Radiol Nucl Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2010.0944","article-title":"Characterization of extrahepatic distribution of Tc-99m macroaggregated albumin in hepatic perfusion imaging studies prior to yttrium-90 microsphere therapy","volume":"26","author":"Jiang M","year":"2011","unstructured":"Jiang M, Nowakowski FS, Wang J, et al.. Characterization of extrahepatic distribution of Tc-99m macroaggregated albumin in hepatic perfusion imaging studies prior to yttrium-90 microsphere therapy. Cancer Biother Radiopharm. 2011, 26:511-8. 10.1089\/cbr.2010.0944","journal-title":"Cancer Biother Radiopharm"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/00003072-199203000-00015","article-title":"Recanalized umbilical vein in a patient with a hepatoma","volume":"17","author":"Levine GM","year":"1992","unstructured":"Levine GM, Slavin JD Jr, Epstein NF, Spencer RP. Recanalized umbilical vein in a patient with a hepatoma. Clin Nucl Med. 1992, 17:228-30. 10.1097\/00003072-199203000-00015","journal-title":"Clin Nucl Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e31821a2bb5","article-title":"Macroaggregated albumin injected in hepatic artery visualized in a recanalized paraumbilical vein","volume":"37","author":"Gupta A","year":"2012","unstructured":"Gupta A, Levitin A, Shrikanthan S. Macroaggregated albumin injected in hepatic artery visualized in a recanalized paraumbilical vein. Clin Nucl Med. 2012, 37:80-1. 10.1097\/RLU.0b013e31821a2bb5","journal-title":"Clin Nucl Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1177\/20101058231154666","article-title":"Review of outcomes of combination therapy using yttrium 90 radioembolization and sorafenib\/nivolumab for HCC with hepatic vein or IVC invasion","volume":"32","author":"Chung S","year":"2023","unstructured":"Chung S, Gogna A, Chandramohan S, et al.. Review of outcomes of combination therapy using yttrium 90 radioembolization and sorafenib\/nivolumab for HCC with hepatic vein or IVC invasion. Proc Singapore Healthc. 2023, 32:1-4. 10.1177\/20101058231154666","journal-title":"Proc Singapore Healthc"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-016-1555-3","article-title":"Assessing intra-arterial complications of planning and treatment angiograms for Y-90 radioembolization","volume":"40","author":"Ahmed O","year":"2017","unstructured":"Ahmed O, Patel MV, Masrani A, et al.. Assessing intra-arterial complications of planning and treatment angiograms for Y-90 radioembolization. Cardiovasc Intervent Radiol. 2017, 40:704-11. 10.1007\/s00270-016-1555-3","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/186449-pretreatment-embolization-of-tumoral-arteriovenous-fistula-associated-with-recanalized-umbilical-vein-shunt-in-a-case-of-hepatocellular-carcinoma-with-hepatic-vein-and-inferior-vena-cava-invasion","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:04:27Z","timestamp":1793689467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/186449-pretreatment-embolization-of-tumoral-arteriovenous-fistula-associated-with-recanalized-umbilical-vein-shunt-in-a-case-of-hepatocellular-carcinoma-with-hepatic-vein-and-inferior-vena-cava-invasion"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,6]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.44784","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,6]]}}}